Clinical Relevance and Drug Modulation of PPAR Signaling Pathway in Triple‐Negative Breast Cancer: A Comprehensive Analysis.
- Published in:
- PPAR Research, 2024, v. 2024, p. 1, doi. 10.1155/ppar/4164906
- By:
- Publication type:
- Article
Works matching IS 1687-4757 AND VI 2024 AND DT 2024
Results: 5
1
2
Mangiferin and EGCG Compounds Fight Against Hyperlipidemia by Promoting FFA Oxidation via AMPK/PPARα.
- Published in:
- PPAR Research, 2024, v. 2024, p. 1, doi. 10.1155/ppar/7178801
- By:
- Publication type:
- Article
3
Systemic and Lung Inflammation and Oxidative Stress Associated With Behavioral Changes Induced by Inhaled Paraquat Are Ameliorated by Carvacrol.
- Published in:
- PPAR Research, 2024, v. 2024, p. 1, doi. 10.1155/2024/4049448
- By:
- Publication type:
- Article
4
Shared Mechanisms in Pparγ1sv and Pparγ2 Expression in 3T3‐L1 Cells: Studies on Epigenetic and Positive Feedback Regulation of Pparγ during Adipogenesis.
- Published in:
- PPAR Research, 2024, v. 2024, p. 1, doi. 10.1155/2024/5518933
- By:
- Publication type:
- Article
5
PPARG and the PTEN-PI3K/AKT Signaling Axis May Cofunction in Promoting Chemosensitivity in Hypopharyngeal Squamous Cell Carcinoma.
- Published in:
- PPAR Research, 2024, v. 2024, p. 1, doi. 10.1155/2024/2271214
- By:
- Publication type:
- Article